ITTN – Chairman of the Board.

Bar–Ilan Research & Development company of Bar-Ilan University

Mr. Kenan has a Cum Laude M.Sc. degree in Agriculture Sciences from the Hebrew University and a Diploma in Business Administration from Henley Management School of Brunel University. In addition to his academic background Mr. Kenan is highly experienced in the business side of the High Tech' industry. He was appointed as the CEO of Bar Ilan Research and Development Company in 2003. Previously he was the CEO of an AgBio company for 4 years. Prior to this position Mr. Kenan served, for more than 7 years, as a Director of Sales and Customer Services at the local distributor in Israel of Merck Sharp and Dhome (MSD – one of the largest pharmaceutical companies in the world), responsible for tens of millions of $ turnover per year.

ITTN – Director

Yeda - Research & Development of Weizmann Institute

Mr. Naiberg holds an LL.M. degree from the University of Connecticut School of Law and an LL.B. degree from the Hebrew University of Jerusalem. Prior to his appointment as Yeda's CEO, Mr. Naiberg served as Yeda's General Counsel for six years. Before joining Yeda, Mr. Naiberg worked for a private law firm specializing in intellectual property, privacy and cyberspace law.

ITTN – Director

BGN - Ben-Gurion University of the Negev

Mr. Cohen joined BGN in 2004, bringing to the position 20 years of managerial experience. Prior to joining BGN, Mr. Cohen was the Deputy General Manager of Pharma-Israel – The Multinational Pharmaceutical Companies Association. Previously, he was the Director of Finance & Business Development for Novartis Consumer Health and Gerber Baby Food at its regional offices. He began his managerial career at Kibbutz Harish, where he served as its General Manager. Mr. Cohen currently sits on the boards of BotanoCap, OmniLogos, Amorphical, MultiPon, PixelScan and other privately-held companies. He also sits on the board of Deutsche Telekom Labs at BGU. Mr. Cohen holds an Executive MBA from the University of Bradford, UK, and a B.A. in Economics from Ruppin Academic Center.

ITTN – Director

Ramot - Technology Transfer of Tel Aviv University

Dr. Weinfeld serves as CEO of Ramot, bringing to the position over twenty years of industry and technology transfer experience.
Prior to assuming his current position, Dr. Weinfeld was Executive Vice President, Business Development at Ramot. He joined Ramot in March 2001 as VP Intellectual Property and Business Development. Prior to joining Ramot, Dr. Weinfeld was Director of Image Guided Surgery and Intellectual Property at Biosense Webster, a Johnson & Johnson company, and was a member of the management team in Israel. 
Before that, he served in a number of project and product managerial positions in the R&D and Marketing Departments of Elscint Ltd.'s Nuclear Medicine Division (now part of GE Medical). Dr. Weinfeld holds a PhD degree in Physics from Tel Aviv University.

ITTN - Director of IT

Yissum - Technology Transfer of the Hebrew University

Mr. Huberman is responsible for the technical infrastructure necessary to support both ITTN and Yissum’s business processes and application systems. He is further responsible for business intelligence at Yissum and handles special projects. Prior to joining Yissum in 2004, Mr. Huberman was the co-founder of Artigon, served as part of the R&D team at Orgenics (AMEX: IMA) and as the Head of IP and R&D at MedisEl (NASDAQ: MDTL). He holds an MSc. in structural biology and a BSc. in biology from the Hebrew University, a diploma in computer & electronics and has continued his marketing and business studies at the Hebrew University.